glp-1 agonists reduce inflammation Central glucagon-like peptide 1 receptor activation inhibits Toll-like receptor agonist-induced inflammation: Cell Metabolism GLP-1 Receptor Agonists: A New

Setriais a registered trademark of KYOWA HAKKO BIO Co., Ltd

Zalachoras, I., Hollis, F., Ramos-Fernndez, E., Trovo, L., Sonnay, S., Geiser, E., Preitner, N., Steiner, P., Sandi, C., & Morat, L

Research on growth hormone's neuroprotective properties suggests potential applications beyond cognitive enhancement

Pancreas GLP-1 and GIP stimulate insulin secretion GLP-1 suppresses glucagon secretion during hyperglycemia GIP suppresses glucagon secretion during hyperglycemia and stimulates secretion during euglycemia and hypoglycemia Brain GLP-1 and GIP suppress hunger Stomach GLP-1 slows gastric emptying Fat tissue GIP increases fatty acid and glucose uptake by fat tissue [1,2,3] Tirzepatide Tirzepatide is a dual GLP-1 / GIP receptor agonist that mimics the actions of GLP-1 and GIP